bioMérieux

Founded in 1963, bioMérieux is a multinational biotechnology company headquartered in Marcy-l'Étoile, France. The company specializes in several key business categories, namely Clinical Applications, Industrial Applications, Molecular Biology, Microbiology, and Immunoassays. bioMérieux is known for developing and providing a variety of instruments and reagents for the diagnosis of infectious diseases, cardiovascular emergencies, and targeted cancers under its Clinical Applications segment. In the realm of Industrial Applications, the company offers microbial control solutions tailored for the pharmaceutical, cosmetic, and food production industries. Furthermore, the company has a strong focus on Molecular Biology, offering advanced molecular diagnostic technologies to detect pathogens and genetic diseases. As for Microbiology, bioMérieux supplies a comprehensive array of culture media and automated systems essential for bacterial growth and detection. Lastly, the Immunoassays segment includes automated immunoassay systems and reagents designed for precisely determining specific proteins and markers. bioMérieux's portfolio of key brands comprises VITEK, known for microbial identification and antibiotic susceptibility testing, BIOFIRE which provides molecular biology systems for syndromic infectious disease testing, VIDAS, an immunoassay platform for protein analysis and detection, BACT/ALERT, which includes fully automated systems for the detection of microbes in blood products and sterile body fluids, and Gene Up, a real-time PCR system utilized for food pathogen detection. With a global operational footprint, bioMérieux's products and services are sold in over 160 countries. Among the most important markets with considerable sales and market presence are the United States, France, China, Brazil, and Italy. These nations are key contributors to the company's international reach and commercial success. (Powered by AI)